Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial

Eric Lawitz, Jay Lalezari, Tarek Hassanein, Kris V. Kowdley, Fred Poordad, Aasim Sheikh, Nezam H. Afdhal, David Bernstein, Edwin DeJesus, Bradley Freilich,

The Lancet Infectious Diseases · 2013 · 328 citations · 16 references

Concepts

References

16